MedPath
HSA Approval

AMLONG TABLET 5 mg

SIN12325P

AMLONG TABLET 5 mg

AMLONG TABLET 5 mg

June 23, 2003

EURO ASIA MEDICO PTE. LTD.

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEURO ASIA MEDICO PTE. LTD.
Licence HolderEURODRUG LABORATORIES SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

MICRO LABS LTD

Active Ingredients

AMLODIPINE BESYLATE EQV AMLODIPINE

5 mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMLONG TABLET 5 mg - HSA Approval | MedPath